Posted on 2月 21, 20232/21/23
Critical Success Factors for Launching Products with Orphan Drug Designation
Posted on 7月 27, 20227/27/22
EVERSANA’s Continued Commitment to Rare Disease
Posted on 5月 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 4月 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on 4月 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease
Posted on 3月 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on 10月 14, 202110/14/21
Webinar: Discover Patient Support Program Needs for Patients with Rare Diseases
Posted on 10月 4, 202110/4/21